查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370221

非侵入性产前检测市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况：

2022年，全球无创产前检测市场规模达34亿美元。展望未来，IMARC集团预计到2028年市场规模将达到85亿美元，2023-2028年复合年增长率（CAGR）为17.2%。

非侵入性产前检测 (NIPT) 是对孕妇的血液样本进行产前筛检的一种形式，以检测胎儿是否有异常。此测试主要用于透过分析母亲血液中的DNA 片段来诊断遗传性疾病，例如唐氏症（或21 三体症）、爱德华兹症候群（或18 三体症）、帕陶氏症（或13 三体）和特纳氏症。该程序消除了各种不稳定和侵入性程序的需要，例如绒毛膜绒毛取样（CVS），并且可以在怀孕九週后进行。

胎儿遗传性疾病的日益普及是推动市场成长的关键因素之一。此外，生命科学和医疗保健产业领域的技术进步也为市场提供了推动力。例如，DNA定序技术、再生医学的发展和分子研究的突破为在原始阶段对抗任何严重疾病的机会创造了巨大的可能性。此外，产前检测接受度的提高，以及大众健康意识的提高以及对此类检测的好处和意义的认识的提高，也推动了市场的成长。医疗保健提供者以及准父母正在采用替代方法来诊断其他遗传性疾病，包括脊柱裂、腭裂和镰状细胞性贫血，并在胎儿发育的早期阶段进行治疗。此外，高龄产妇（35 岁或以上）生育趋势的转变也对市场成长有正面影响。高龄产妇可能会导致许多健康併发症，例如高血压、生育能力下降、流产风险以及胎儿染色体异常风险增加。

本报告回答的关键问题

  • 2022年全球非侵入性产前检测市场规模有多大？
  • 2023-2028年全球非侵入性产前检测市场的预期成长率为何？
  • 推动全球无创产前检测市场的关键因素是什么？
  • COVID-19对全球无创产前检测市场有何影响
  • 根据产品类型，全球非侵入性产前检测市场的细分情况如何？
  • 根据检测类型，全球无创产前检测市场的细分情况如何？
  • 基于该技术的全球无创产前检测市场格局如何？
  • 基于方法的全球无创产前检测市场区隔如何？
  • 基于应用的全球无创产前检测市场区隔如何？
  • 基于最终用户的全球无创产前检测市场的细分情况如何？
  • 全球无创产前检测市场的重点区域有哪些？
  • 全球无创产前检测市场的主要企业/参与者有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球无创产前检测市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 耗材
    • 市场走向
    • 市场预测
  • 仪器
    • 市场走向
    • 市场预测

第 7 章：按测试类型分類的市场

  • 马特尼 21
    • 市场走向
    • 市场预测
  • 和谐
    • 市场走向
    • 市场预测
  • 帕纳罗玛
    • 市场走向
    • 市场预测
  • 验证
    • 市场走向
    • 市场预测
  • 漂亮
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：依科技分類的市场

  • NGS
    • 市场走向
    • 市场预测
  • 全基因组定序
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：依方法划分市场

  • 超音波检测
    • 市场走向
    • 市场预测
  • 生化筛选试验
    • 市场走向
    • 市场预测
  • 母体血浆检测中的游离 DNA
    • 市场走向
    • 市场预测
  • 母体血液检测中的胎儿细胞
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按应用分類的市场细分

  • 三体性
    • 市场走向
    • 市场预测
  • 微缺失症候群
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 诊断实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 12 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 13 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 14 章：价值链分析

第 15 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies, Inc.
    • Berry Genetics Inc.
    • BGI Genomics Co. Ltd.
    • Eurofins Scientific Services Limited
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Igenomix
    • Illumina Inc.
    • Laboratory Corporation
    • Natera Inc.
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Yourgene Health plc
Product Code: SR112023A2086

Abstract

Market Overview:

The global non-invasive prenatal testing market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 17.2% during 2023-2028.

Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman's blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother's blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global non-invasive prenatal testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, test type, technology, method, application and end-user.

Breakup by Product Type:

Consumables

Instruments

Breakup by Test Type:

Materni 21

Harmony

Panaroma

Verifi

NIFTY

Others

Breakup by Technology:

NGS

WGS

Others

Breakup by Method:

Ultrasound Detection

Biochemical Screening Tests

Cell-Free DNA in Maternal Plasma Tests

Fetal Cells in Maternal Blood Tests

Others

Breakup by Application:

Trisomy

Microdeletion Syndrome

Others

Breakup by End-User:

Hospitals

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the top non invasive prenatal testing companies key players being Agilent Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F. Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc.

Key Questions Answered in This Report

  • 1. What was the size of the global non-invasive prenatal testing market in 2022?
  • 2. What is the expected growth rate of the global non-invasive prenatal testing market during 2023-2028?
  • 3. What are the key factors driving the global non-invasive prenatal testing market?
  • 4. What has been the impact of COVID-19 on the global non-invasive prenatal testing market
  • 5. What is the breakup of the global non-invasive prenatal testing market based on the product type?
  • 6. What is the breakup of the global non-invasive prenatal testing market based on the test type?
  • 7. What is the breakup of the global non-invasive prenatal testing market based on the technology?
  • 8. What is the breakup of the global non-invasive prenatal testing market based on the method?
  • 9. What is the breakup of the global non-invasive prenatal testing market based on the application?
  • 10. What is the breakup of the global non-invasive prenatal testing market based on the end-user?
  • 11. What are the key regions in the global non-invasive prenatal testing market?
  • 12. Who are the key companies/players in the global non-invasive prenatal testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Non-Invasive Prenatal Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Materni 21
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Harmony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Panaroma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Verifi
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 NIFTY
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 NGS
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 WGS
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Method

  • 9.1 Ultrasound Detection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Screening Tests
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Fetal Cells in Maternal Blood Tests
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Trisomy
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Microdeletion Syndrome
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Diagnostic Laboratories
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies, Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Berry Genetics Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BGI Genomics Co. Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Eurofins Scientific Services Limited
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 GE Healthcare
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Igenomix
      • 16.3.7.1 Company. Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Illumina Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Laboratory Corporation
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Natera Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Perkinelmer Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Yourgene Health plc
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2022
  • Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2022
  • Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
  • Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
  • Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2023-2028
  • Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Non-Invasive Prenatal Testing Market Structure
  • Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players